C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
This is the first major brand refresh of CanSinoBIO since its inception in 2009
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Subscribe To Our Newsletter & Stay Updated
